Sonderforschungsbereich 630


    The topics of the sessions will include Medicinal Chemistry, Natural Product Chemistry, Pathogen Biology, Host-Pathogen-Interaction, and Theoretical Chemistry and Computer-aided Drug Design.

    Short talks will be selected from the submitted abstracts.

    There will also be a prolonged evening postersession to discuss contributions of our young investigators.

    Here is a preliminary program that still might be affected by changes.
    Titles of the talks will be supplemented.

    download program


    Wednesday, November 20

    11:00 Welcome

    Drug Development: Antibiotics and Resistances

    11:15 Thomas Henkel
    Strategies for molecular prevention of bacterial and fungal infections - represent Glycolipids a new option?

    11:50 Peter Hammann
    Status and Perspectives of Antibiotics: Special focus on Natural Products

    12:25 Robert Beardmore
    Mathematical and Laboratory Models of Antibiotic Use: predicting bacterial clearance at sub-lethal dosages in the presence of chromosomal multidrug resistance adaptation

    Natural Product Chemistry

    14:30 Tobias Gulder
    Exploring and Exploiting Bacterial Natural Product Biosynthesis

    15:05 Peter Seeberger
    Preventing and Curing Infectious Diseases: Carbohydrate Vaccines and Continuous Flow Synthesis

    15.40 Short Talk: Usama Abdelmohsen
    New Bioactive Natural Products Discovery from Marine Sponge-Associated Actinomycetes

    Pathogen Biology / Drug Discovery

    16:15 Alan Fairlamb
    Drug Discovery for neglected diseases – successes failures and lessons learned

    16:50 Simon Croft
    Challenges and opportunities for the development of new treatments for leishmaniasis

    17:25 Short Talk: Alena Zikova
    Designing an effective inhibitor of Trypanosoma brucei F1-ATPase

    18:00 Evening Poster Session

    Thursday, November 21

    Pathogen Biology I

    9:00 Gerald Späth
    Anti-leishmanial drug development efforts at Institut Pasteur: From basic parasite biology to drug target identification and validation

    9:35 Ger van Zandbergen
    Leishmania interaction with human macrophages and T cells

    10.10 Short Talk: Iris Gonzalez-Leal
    Cathepsin-deficient dendritic cells present alterations in maturation and cytokine production in response to Leishmania major infection 

    Pathogen Biology 

    10:45 Steffen Rupp
    A screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives and their Target

    11:20 Axel Brakhage
    Pathobiology of Aspergillus fumigatus and the discovery of novel compounds

    Structure Based Medicinal Chemistry

    13:25 François Diederich
    Structure-Based Design in the Generation and Optimization of New Lead Compounds Against Infectious Diseases

    14:00 Short Talk: Alexander Titz
    Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes

    14:15 Maurizio Botta
    Design, synthesis and biological evaluation of human DDX3 inhibitors with multiple antiviral activities

    14.50 Short Talk: Julia Kirchebner
    Development of CHVB_0032 – a small molecule inhibitor of chikungunya virus

    Drug Development: Ligand Binding

    15:25 Helena Danielson
    From Fragments to Transition State Analogues – Drug Discovery using SPR Biosensor Technology

    16:00 Jon Essex
    Protein-Ligand Binding by Free Energy Simulations: Issues, Successes and Failures

    Friday, November 22

    Computer-aided Drug  Design

    9:00 Samuel de Visser
    Computational Bioengineering of Non-heme iron dioxygenases: How to change the enantioselectivity of the enzyme

    9:35 Xavier Barril
    Modulation of chemotactic responses with protein-protein interfacial binders discovered through structure-based methods

    10.10 Short Talk: Wook Lee
    The mechanism of how KasA is activated by its own substrate

    Natural Product Chemistry

    10:45 Hans-Dieter Arndt
    Peptide natural products and small molecules as tools in Chemical Biology

    11:20 Jeroen Dickschat
    Natural Products from Microorganisms – Structure Elucidation, Synthesis and Biosynthesis

    11.55 Short Talk: Michael Zender
    Discovery and Biophysical Characterization of 2-Amino-Oxadiazoles as Novel Antagonists of PqsR, an Important Regulator of Pseudomonas aeruginosa Virulence  

    12:10 Poster Prize

    12:25 Closing Remarks


    Hinweis zum Datenschutz

    Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Facebook weitergeleitet. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung.

    Hinweis zum Datenschutz

    Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Twitter weitergeleitet. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung.


    Collaborative Research Center 630
    Recognition, Preparation and Functional Analysis of Agents against Infectious Diseases
    Am Hubland
    97074 Würzburg

    Tel.: +49 931 31-85361

    Suche Ansprechpartner

    Hubland Süd, Geb. C1